摘要: Publication » 456 Comparison of overall survival between the life expectancy and the estimated outcome in patients who underwent radical nephrectomy or partial nephrectomy for renal cell carcinoma.DOI: 10.1016/S1569-9056(13)60940-9 年份: 2013 ...
This may be what will happen with our approach to managing renal cell carcinoma (RCC). It has been estimated that, in 2008, approximately 55,000 new renal tumors were diagnosed in the United States, resulting in 13,000 deaths, and similar figures are expected throughout the world. Renal ...
For patients with early-stage disease who have undergone treatment, education about possible relapse should be provided. For patient education information, see Renal Cell Cancer. Presentation History Renal cell carcinoma (RCC) may remain clinically occult for most of its course. The classic triad of...
Renal Cell Carcinoma (RCC) is the most common form of kidney cancer, with clear cell RCC (ccRCC) representing about 85% of all RCC tumors. There are limited curable treatments available for metastatic ccRCC because this disease is unresponsive to conventional targeted systemic pharmacotherapy. Exosom...
Purpose:To investigate clinical significance of extrarenal manifestations of renal cell carcinoma in earlier diagnosis and prognosis estimation of renal cell carcinoma. Methods:From 1988 to 2001,clinical date of 372 cases of renal cell carcinoma confirmed by operation and pathology were reviewed retrospect...
The kidney is a vital organ responsible for maintaining homeostasis in the human body. However, renal cell carcinoma (RCC) is a common malignancy of the urinary system and represents a serious threat to human health. Although the overall survival of RCC
The potential benefit of neoadjuvant toripalimab plus axitinib in cases with clear cell renal cell carcinoma (ccRCC) and inferior vena cava tumor thrombus (IVC-TT) remains unclear. NEOTAX was a phase 2 study to investigate the efficacy and safety of neoadjuvant toripalimab plus axitinib in pati...
Studies further suggest a connection between ferroptosis and various kidney diseases: targeted iron-induced cell death may provide therapeutic benefit in acute or chronic kidney injury, diabetic nephropathy, and renal cell carcinoma [4,5,6,7]. Moreover, drugs that counteract lipid peroxidation or ...
cell carcinoma Papillary Chromophobe Others ISUP grade, n (%) Low grade ≤ 2 High grade ≥ 3 Tumor necrosis, n (%) Sarcomatoid differentiation, n (%) Lymph node metastasis, n (%) Pathological T stage, n (%) T1 T2 T3 T4 77 (75–89) ...
Micall2, as a pro-tumorigenic gene marker specifically related to clear cell renal cell carcinoma (ccRCC), contributes to the malignant phenotype of ccRCC.Predictive models for human breast cancer can find parallels in the study of canine mammary gland tumors. Human breast cancer and canine mammar...